Published in Br J Cancer on August 23, 2011
Non-Biased Enrichment Does Not Improve Quantitative Proteomic Delineation of Reovirus T3D-Infected HeLa Cell Protein Alterations. Front Microbiol (2012) 0.91
Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem (2012) 0.89
The oncolytic virus, pelareorep, as a novel anticancer agent: a review. Invest New Drugs (2015) 0.88
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity. World J Methodol (2016) 0.82
Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis. PLoS One (2013) 0.82
Quantification of the host response proteome after mammalian reovirus T1L infection. PLoS One (2012) 0.81
Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells. Front Oncol (2014) 0.80
Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma. J Otolaryngol Head Neck Surg (2015) 0.79
Reovirus in cancer therapy: an evidence-based review. Oncolytic Virother (2014) 0.78
Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus. Viruses (2015) 0.78
Comparative proteomic analyses demonstrate enhanced interferon and STAT-1 activation in reovirus T3D-infected HeLa cells. Front Cell Infect Microbiol (2015) 0.76
Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host Interactions. PLoS One (2016) 0.76
Mitochondrial p53 Contributes to Reovirus-Induced Neuronal Apoptosis and Central Nervous System Injury in a Mouse Model of Viral Encephalitis. J Virol (2016) 0.76
HeLa cell response proteome alterations induced by mammalian reovirus T3D infection. Virol J (2013) 0.76
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer. J Clin Med (2015) 0.76
p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells. Vet Res (2016) 0.75
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer. PLoS One (2017) 0.75
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
Polypeptide components of virions, top component and cores of reovirus type 3. Virology (1969) 9.83
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med (2004) 5.48
Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer (2009) 5.12
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A (2006) 4.68
Reovirus therapy of tumors with activated Ras pathway. Science (1998) 4.15
Role of NF-kappaB in p53-mediated programmed cell death. Nature (2000) 3.62
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J (1998) 2.62
Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst (2001) 2.27
A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res (2008) 2.18
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol Ther (2008) 1.81
Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol Ther (2007) 1.80
Oncolytic reovirus against ovarian and colon cancer. Cancer Res (2002) 1.73
Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB. J Virol (2000) 1.68
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res (2003) 1.59
Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin Cancer Res (2008) 1.56
Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma. Clin Cancer Res (2009) 1.50
Reovirus oncolysis of human breast cancer. Hum Gene Ther (2002) 1.45
The preferential cytotoxicity of reovirus for certain transformed cell lines. Arch Virol (1977) 1.39
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin Cancer Res (2010) 1.35
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells. Mol Cancer (2009) 1.32
Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol (1978) 1.32
Reovirus therapy of lymphoid malignancies. Blood (2002) 1.28
Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling. Cancer Res (2010) 1.19
Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem (2003) 1.14
Loss of nuclear factor-kappaB is tumor promoting but does not substitute for loss of p53. Cancer Res (2004) 1.09
Updates on p53: modulation of p53 degradation as a therapeutic approach. Br J Cancer (2008) 1.07
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene (2010) 0.98
KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2006) 0.92
Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D. J Virol (2005) 0.88
Oncolytic viruses: an approved product on the horizon? Mol Ther (2010) 0.86
Induction of p53-dependent apoptosis in HCT116 tumor cells by RNA viruses and possible implications in virus-mediated oncolysis. Cell Cycle (2004) 0.84
Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells. Cancer Lett (2009) 0.83
Calcium chloride acidosis. J Physiol (1923) 33.02
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA (1998) 3.81
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation (2001) 3.33
Identification of an origin of bidirectional DNA replication in mammalian chromosomes. Cell (1990) 3.27
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation (1999) 2.59
Surgical site infection after groin hernia repair. Br J Surg (2004) 2.54
The relation of oxygen evolution to carbon assimilation with isolated chloroplasts. Biochim Biophys Acta (1967) 2.29
Microbiologic study of street heroin and injection paraphernalia. J Infect Dis (1974) 2.10
Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol (1995) 2.07
Chromosomal deletion and retinoblastoma. N Engl J Med (1976) 1.88
Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.84
A transposable element that splits the promoter region inactivates a Drosophila cuticle protein gene. Proc Natl Acad Sci U S A (1982) 1.81
Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol (1999) 1.79
Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol (1995) 1.79
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1. Oncogene (2006) 1.78
Emetine allows identification of origins of mammalian DNA replication by imbalanced DNA synthesis, not through conservative nucleosome segregation. EMBO J (1991) 1.65
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. QJM (2003) 1.55
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol (1998) 1.45
In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant (1999) 1.45
Association between indoor residential contamination with methyl parathion and urinary para-nitrophenol. J Expo Anal Environ Epidemiol (1997) 1.41
Medical students health habits: do future physicians have healthy lifestyles? Wis Med J (1995) 1.39
Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res (2001) 1.38
Bovine tuberculosis in an Eurasian otter. Vet Rec (2009) 1.37
Identification of sonic hedgehog as a candidate gene responsible for the polydactylous mouse mutant Sasquatch. Curr Biol (1999) 1.36
Superior vena caval obstruction. Is it a medical emergency? Am J Med (1981) 1.33
Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation (1999) 1.29
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation (1995) 1.26
Targeting the p53-MDM2 interaction to treat cancer. Br J Cancer (2004) 1.25
Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys (1997) 1.22
A comparison of digital retinal images and 35 mm colour transparencies in detecting and grading diabetic retinopathy. Diabet Med (1998) 1.21
A gene with sequence similarity to Drosophila engrailed is expressed during the development of the neural tube and vertebrae in the mouse. Development (1988) 1.20
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17
C- and Q-band polymorphisms in the chromosomes of three human populations. Ann Hum Genet (1976) 1.16
Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry (1983) 1.15
Delayed light studies on photosynthetic energy conversion. II. Effect of electron acceptors and phosphorylation cofactors on the millisecond emission from chloroplasts. Biochim Biophys Acta (1969) 1.13
A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis. Cancer Genet Cytogenet (1981) 1.12
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation (2001) 1.12
Case of tuberous sclerosis and haemorrhagic retinopathy (with fundus photographs). Br Med J (1967) 1.11
The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. Am J Hum Genet (2000) 1.09
Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation (1995) 1.09
Increased lymphocyte replicative index following 2,4-dichlorophenoxyacetic acid herbicide exposure. Cancer Causes Control (2000) 1.08
Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. Eur Heart J (1995) 1.08
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci (2001) 1.08
Dosimetric verification of a commercial inverse treatment planning system. Phys Med Biol (1999) 1.08
Cellular fatty acid composition of Campylobacter pylori from primates and ferrets compared with those of other campylobacters. J Clin Microbiol (1989) 1.08
Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone. Int J Pept Protein Res (1995) 1.08
ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China. J Am Geriatr Soc (1995) 1.07
p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene (2010) 1.06
Population structure of Barra (Outer Hebrides). Ann Hum Genet (1976) 1.06
Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest (1992) 1.03
E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models. Cancer Gene Ther (2007) 1.02
Subcellular distribution of copper in the liver of fetal deer in the last month of gestation. Res Vet Sci (1990) 1.02
Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population. Circulation (1991) 1.02
Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J Clin Invest (1992) 1.01
Homicidal somnambulism: a case report. Sleep (1994) 1.01
In vivo skeletal response and biomechanical assessment of two novel polyalkenoate cements following femoral implantation in the female New Zealand White rabbit. J Mater Sci Mater Med (1998) 0.99
A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci (1999) 0.99
The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A (1995) 0.98
The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status. Oncogene (2010) 0.98
Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer. Gene Ther (2004) 0.98
Carbon dioxide and the reduction of indophenol and ferricyanide by chloroplasts. Plant Physiol (1967) 0.97
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood (1990) 0.97
Nucleotide sequence analysis of three cDNAs coding for Poa p IX isoallergens of Kentucky bluegrass pollen. J Biol Chem (1991) 0.96
Children's attentional skills and road behavior. J Exp Psychol Appl (2001) 0.95
Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer. Int J Radiat Oncol Biol Phys (2001) 0.95
Electrogenic pump and a Ca(2+)- dependent K+ conductance contribute to a posttetanic hyperpolarization in lamprey sensory neurons. J Neurophysiol (1996) 0.95
Retinopathy of prematurity: are we screening too many babies? Eye (Lond) (2002) 0.94
Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol (1987) 0.94
The segregation of human chromosome polymorphisms. Ann Hum Genet (1976) 0.92
Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle. Circulation (1993) 0.92
Procedure-specific surgical site infection rates and postdischarge surveillance in Scotland. Infect Control Hosp Epidemiol (2006) 0.90
Outcome, functional recovery and unmet needs following acute stroke. Experience of patient follow up at 6 to 9 months in a newly established stroke service. Scott Med J (2002) 0.90
Diagnostic value of thermography in extracranial carotid occlusive disease. Trans Am Neurol Assoc (1965) 0.90
Acute respiratory failure in motor neuron disease. Arch Neurol (1983) 0.90
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro. Br J Cancer (2006) 0.90
Differential expression of thyrotropin receptor mRNA in the porcine heart. Thyroid (1997) 0.90
Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis. Osteoarthritis Cartilage (2008) 0.89
L-Glutaric acidemia: investigation of a patient and his family. Pediatrics (1979) 0.89
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. J Clin Oncol (1990) 0.89
Macronutrient intake and whole body protein metabolism following resistance exercise. Med Sci Sports Exerc (2000) 0.89
The intrinsic function of a motor system--from ion channels to networks and behavior. Brain Res (2000) 0.89
The influence of calcium to phosphate ratio on the nucleation and crystallization of apatite glass-ceramics. J Mater Sci Mater Med (2001) 0.89
Deciphering cancer complexities in genetically engineered mice. Cold Spring Harb Symp Quant Biol (2005) 0.88
Naproxen-metabolism, excretion and comparative pharmacokinetics. Scand J Rheumatol Suppl (1973) 0.88
Indomethacin blockade of renal PGE-synthesis: effect on total renal and tubular function and plasma renin concentration in hydropenic rats and on their response to isotonic saline. Acta Physiol Scand (1975) 0.88
Remifentanil prevents an increase in intraocular pressure after succinylcholine and tracheal intubation. Br J Anaesth (1998) 0.88
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia (1999) 0.88
Campylobacter pyloridis and gastritis in children. Lancet (1986) 0.88
Sleep apnea syndrome after poliomyelitis. Am Rev Respir Dis (1983) 0.88
Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy. Cell Death Dis (2013) 0.87
Attenuated reovirus displays oncolysis with reduced host toxicity. Br J Cancer (2010) 0.87
Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. Br J Cancer (1991) 0.87
A gene for FG syndrome maps in the Xq12-q21.31 region. Am J Med Genet (1997) 0.87
Cytogenetic changes induced in human diploid fibroblasts by tsA58 SV40 at permissive and restrictive temperatures. Mutat Res (1985) 0.87
Glass ceramic approach to controlling the properties of a glass-ionomer bone cement. Biomaterials (1991) 0.87